secwatch.observer — SEC 8-K summary ====================================== Issuer: RAPID MICRO BIOSYSTEMS, INC. (RPID) CIK: 0001380106 Form: 8-K Filed at: 2026-11-16T21:14:35+00:00 Accession: 0001104659-26-128328 Event type: m_and_a Sentiment: positive Materiality: 0.85 Item codes: 1.01, 8.01, 9.01 LLM model: deepseek-v4.1-flash:cloud@v2 Merck KGaA to buy Rapid Micro Biosystems for $0.75/share cash in tender offer ----------------------------------------------------------------------------- - Merck KGaA units Parent and EMD Holdings NewCo II signed a merger agreement on Nov 16, 2026 to buy all RPID Class A and Class B shares for $0.75 cash per share. - Tender offer runs 10 business days initially, conditioned on majority of Class A shares plus pre-funded warrant shares; merger then closes under DGCL 251(h) with no stockholder vote. - RPID board unanimously approved and recommends the deal; holders of ~19.58% of shares, including all directors and some executives, signed tender and support agreements. - Company would owe Parent a $1,573,000 termination fee to accept a Superior Proposal or change its recommendation; customary no-shop with fiduciary out applies. - Warrants addressed: $1.955 Series A cashed out, $2.34 Series B bought at Black-Scholes value, $3.35 2025 warrants and $1.00 2018 warrants cancelled for no consideration. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1380106/000110465926128328/0001104659-26-128328-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1380106/000110465926128328/tm2629893d1_8k.htm HTML page: https://secwatch.observer/filing/0001104659-26-128328 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer